Description
Rabies lyssavirus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been chemically modified to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. RABV stock can be used in the development of RABV diagnostics and in vaccine development and R&D.